Sight Sciences, Inc.
- SGHT
- NASDAQ
- Medical devices
- Ophthalmic Medical Devices
- Glaucoma Treatment (OMNI)
$8.26
Today −0.24%Quote Oct 19, 2026, 08:00 PM UTC
+2.48%over the last month
Max drawdown −11.9%From 1-month high −11.5%3 months +64.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Sight Sciences
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients.
Where the money comes from
Q2 2026 revenue $23.4M
- Surgical Glaucoma$20.7M88.6%
- Dry Eye$2.7M11.4%
Sector
Healthcare
Industry
Medical devices
Exchange
NASDAQ
Employees
186
Founded
2010
Market value
$455.0M
Quote Oct 19
Floor
$8.15
1.3% below price
Resistance
$8.28
0.2% above price
Price vs analyst targets
9 analysts
Lowest target
$7.00Highest target
$14.00
$7.00Highest target
$14.00
- Price $8.26
- Average target $10.50
- Analysts' target range
Analysts' average target sits about 27% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SGHTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free